Table 2.
Absent by | Terms | Group | Cumulative Days | p-Value | Odds Ratio (95% CI) | |
---|---|---|---|---|---|---|
Not Absent | Absent | |||||
URID/GID | Term 2 | Control | 12,698 | 70 ** | 0.004 | 0.57 (0.38~0.84) |
LC-Plasma | 12,170 | 38 | ||||
Term 3 | Control | 12,739 | 29 | 0.49 | 1.19 (0.73~1.95) | |
LC-Plasma | 12,175 | 33 | ||||
URID | Term 2 | Control | 12,706 | 62 ** | 0.005 | 0.56 (0.37~0.85) |
LC-Plasma | 12,175 | 33 | ||||
Term 3 | Control | 12,746 | 22 | 0.38 | 1.28 (0.74~2.24) | |
LC-Plasma | 12,181 | 27 | ||||
GID | Term 2 | Control | 12,760 | 8 | 0.45 | 0.65 (0.23~1.89) |
LC-Plasma | 12,203 | 5 | ||||
Term 3 | Control | 12,761 | 7 | 0.84 | 0.90 (0.32~2.54) | |
LC-Plasma | 12,203 | 6 |
Chi-square test is used for statistical analysis. p-value and odds ratio and its 95% confidence interval (CI) are shown. ** represents significant difference between Control and LC-Plasma (p < 0.01). URID represents upper respiratory infectious disease, and GID represents gastrointestinal infectious disease.